In another cross-the-pond deal, US-based Odyssey Therapeutics acquired London-based Rahko, according to reports from The Telegraph. Rahko is developing...
The whole field in five minutes, every morning.
One of our team will be in touch to learn more about your requirements, and provide pricing and access options.
Necessary cookies are always on to ensure the website works. Optional cookies help us understand how the site is used. Privacy Policy